Dr. Marco Carbonare
Attorney at Law (New York)
Solicitor of the Senior Courts of England and Wales
Marco is a partner in the Firm’s Corporate/M&A group and advises on a wide range of cross-border mergers and acquisitions, spin-offs, dual track and other corporate transactions as well as international capital markets transactions, including IPOs, rights issues, Rule 144A investment grade and high yield bonds as well as equity-linked transactions. He is German, US and English law qualified and has extensive international and cross-border transactional experience acting for corporates, with a particular focus on Germany, Switzerland, the Nordics, the United States and China. Marco is also the founder and co-head of the Firm’s Swiss Desk and has extensive experience advising Swiss corporates in connection with international mergers and acquisitions and capital markets transactions. Marco is a native German speaker and is fluent in English.
Marco was based in London from 2000 until 2011 and has been based in the Firm’s Frankfurt office since 2011. Prior to joining the Firm’s London office in 2006, Marco worked for eight years in the Corporate/M&A group of a Tier 1 U.S. firm.
IPOs/spin offs/rights issues: In the ECM space, Marco has advised issuers and underwriters on a large number of high profile subsidiary IPOs and spin-offs by listed entities, rights issues to finance large M&A transactions and some of the world’s largest IPOs. His issuer counsel experience includes the IPOs of Siemens Healthineers by Siemens, Credit Suisse Schweiz by Credit Suisse (abandoned), Covestro by Bayer, Sensirion and the Elkem Group by Chemchina, the spin-off of Uniper by E.ON, the Re-IPO of the RTL Group, the London listing of RHI Magnesita in connection with the acquisition of Magnesita by Austrian company RHI, the IPOs of XXL by EQT and Alimak Hek by Triton, rights issues by Julius Baer, Holcim and Valora to finance acquisitions, the London secondary GDR listing of OMV Petrom and the rights issue and recapitalisation of Lloyds Banking Group during the financial crisis, among many others. Marco also has extensive experience acting for underwriters/financial advisors, including recently on the rights issue of Hapag-Lloyd, the IPO of Varta, the demerger of Metro Wholesale & Food Specialist by Metro, the IPO of Sixt Leasing by Sixt, the spin-off of Osram by Siemens, the spin-off of BUWOG by Immofinanz, the IPOs of Gategroup by HNA (abandoned), Galenica Santé by Galenica, Trivago, Molecular Partners, Cassiopea by Cosmo Pharmaceutical, DKSH, Bravofly and Moneta Money Bank (formerly GE Money Bank) by GE, the rights issue by Lonza to finance the acquisition of Capsugel, the Re-IPO of Van Lanschot, rights issues by Dufry in 2015 and 2014 to finance acquisitions, the rights issue by EFG International to finance the acquisition of BSI, the IPOs of Scandic Hotels by EQT and Gjensidige as well as a large number of IPOs and rights issues on the London Stock Exchange (including Phosagro, Sports Direct, Xchanging, Pharmstandard), among many others.
Mergers and acquisitions: Marco’s experience includes public and private M&A transactions, including acting for Holcim in connection with its merger with Lafarge, acting for Julius Baer in connection with the acquisition of the international wealth management business from Bank of America Merrill Lynch, acting for RHI in connection with the reorganisation and London listing in connection with the acquisition of Magnesita, acting for the financial advisor to Lonza in connection with the acquisition of Capsugel, acting for a European financial institution in connection with an abandoned acquisition, acting on a number of dual track sale processes, acting for Holcim in connection with cross-border corporate transactions, acting for a large European oil and gas group on a number of M&A transactions and joint ventures, acting for a US corporate in connection with a private M&A transaction, acting for eKabel Hessen in connection with the acquisition of the Hessen broadbank cable business from Deutsche Telekom and acting for a number of US corporates in connection with contemplated transactions in Europe.
Debt/Equity-Linked: advising the issuer on the debut Rule 144A yankee bond by LafargeHolcim, Rule 144A yankee bonds by Holcim, SEC-registered bonds by British Telecommunications, Rule 144A high yield bonds by Ovako, Barry Callebaut, CareUK, NorskeSkog and VistaJet and international bond offerings by Syngenta. Transactions as underwriters’ counsel include the fully documented Rule 144A mandatory convertible bond by Bayer to finance the acquisition of Monsanto, the Rule 144A mandatory convertible bond by Volkswagen, Rule 144A high yield bonds by Hapag-Lloyd and ATU and Rule 144A yankee bonds by Merck & Co. KGaA, Novatek and Phosagro.
Marco is recommended as a leading individual by various legal directories, including Chambers, which cites sources stating “Whenever you have a discussion, he brings large groups of people together and finds solutions that work for everyone.” and “Marco is extremely experienced, and has a pragmatic approach to the process and the issues at hand. He really found a good balance of when to push, or hold back to get things done.”
2011 to date Partner, Linklaters, Frankfurt
2006 - 2011 Counsel, Linklaters, London
2000 - 2006 Associate, Skadden, Arps, Slate, Meagher & Flom, London
1998 - 2000 Associate, Skadden, Arps, Slate, Meagher & Flom, Frankfurt/Vienna
1996 - 1998 Judicial Clerk, Court of Appeals, Vienna and Innsbruck
1997 - 1998 Georgetown University Law Center, Washington D.C., Master of Laws (LL.M.)
1996 - 2000 University of Vienna School of Law, Ph.D. in Law (Doctor iuris), with distinction
1991 - 1996 University of Vienna School of Law, J.D. (Magister iuris), Law Degree 1983 - 1991 High School, Bregenz, Austria
English, German, French